Fakhreddin Jamali

Last updated
Fakhreddin Jamali
Fakhreddin Jamali.jpg
Born (1945-05-31) May 31, 1945 (age 80)
Arak, Iran
Education University of British Columbia (PhD)
University of Tehran (Pharm.D.)
Known forfounding the Canadian Society for Pharmaceutical Sciences
SpouseElaheh Keshavarz-Jamali (b. 1945- d. 2020) [1]
Children1 [1]
Awards Alberta Centennial Medal, AAPS fellowship, CSPS fellowship, Killam Professorship
Scientific career
Fields pharmaceutical sciences
Institutions University of Alberta

Fakhreddin Jamali (born May 31, 1945) is an Iranian-Canadian pharmacist. He is a professor emeritus of pharmacy and pharmaceutical sciences at the University of Alberta. He is the founding president of the Canadian Society for Pharmaceutical Sciences, [2] and the editor-in-chief of Journal of Pharmacy and Pharmaceutical Sciences . [3]

Contents

Early life

Fakhreddin was born May 31, 1945, in Arak, Iran to Jamaleddin Jamali and Batoul Rouhani-Jamali. [4] [5]

Career

Jamali's focus has been on drugs action (pharmacodynamics) and disposition (pharmacokinetics) particularly in field of analgesics and antiinfammatory therapy. His earlier work on the stereoselective and stereospecific therapeutic and toxicity of drugs received high peer recognition. [6] He also reported that pain and/or its trauma delays absorption of drugs which may render them ineffective. [7] This is particularly important when a quick action is desired such as pain relief. His group found that inflammatory conditions such as arthritis diminish response to some cardiovascular drugs despite already known increased circulatory concentrations. [8] His group also has reported the mechanism behind the adverse cardiovascular effects of both anti-inflammatory drugs and inflammatory conditions. [9] [10] Jamali has received many national and international awards for his contribution to science and public wellbeing. [11]

References

  1. 1 2 "Dr. Fakhreddin Jamali: Pharmacist, Pharmaceutical Scientist and Mentor".
  2. ↑ "2018 Board of Directors". Cspscanada.org. Retrieved 17 January 2019.
  3. ↑ "Editorial Team". Journals.library.ualberta.ca. Retrieved 12 August 2018.
  4. ↑ "سخنرانی دکتر فخرالدین جمالی در دانشکده داروسازی". Tehran University of Medical Sciences . Retrieved 26 January 2019.
  5. ↑ "کانون سردفتران و دفتریاران". www.notary.ir. Retrieved 26 January 2019.
  6. ↑ Jamali, F.; Mehvar, R.; Pasutto, F. M. (1 September 1989). "Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls" . Journal of Pharmaceutical Sciences. 78 (9): 695–715. doi:10.1002/jps.2600780902. ISSN   0022-3549. PMID   2685226.
  7. ↑ Jamali, Fakhreddin; Kunz-Dober, Cornelia M. (April 1999). "Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery: Pain-mediated altered absorption of ibuprofen". British Journal of Clinical Pharmacology. 47 (4): 391–396. doi:10.1046/j.1365-2125.1999.00902.x. PMC   2014238 . PMID   10233203.
  8. ↑ Abdallah, Yasmeen El Hajj; Chahal, Sukhman; Jamali, Fakhreddin; Mahmoud, Sherif Hanafy (2023). "Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition". Journal of Pharmacy & Pharmaceutical Sciences. 26 11137. doi: 10.3389/jpps.2023.11137 . ISSN   1482-1826. PMC   9990632 . PMID   36942294.
  9. ↑ Aghazadeh-Habashi, Ali; Asghar, Waheed; Jamali, Fakhreddin (1 February 2018). "Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid" . Journal of Pharmaceutical Sciences. 107 (2): 756–763. doi:10.1016/j.xphs.2017.09.020. ISSN   0022-3549. PMID   28989019.
  10. ↑ Asghar, Waheed; Aghazadeh-Habashi, Ali; Jamali, Fakhreddin (1 October 2017). "Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin–angiotensin system in experimental arthritis" . Inflammopharmacology. 25 (5): 543–553. doi:10.1007/s10787-017-0344-1. ISSN   1568-5608. PMID   28389995. S2CID   254576802.
  11. ↑ "Fakhreddin Jamali". International Pharmaceutical Federation.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.